Dr. Martin Zalesak, MD, PhD
Basel Area, Switzerland
M&A Director at Novartis
Pharmaceuticals
Education
Harvard Medical School 2000 — 2008
M.D., Medicine
Massachusetts Institute of Technology 2000 — 2008
PhD, Medical Engineering
University of Pennsylvania 1996 — 2000
BSc, MSc, Chemical Engineering, Graduated Summa Cum Laude, Dean's List all years
Atlantic College 1994 — 1996
International Baccalaureate, Advanced Mathematics, Physics, Chemistry, High School Valedictorian: 44/45 points on International Baccalaureate
Experience
Novartis December 2014 - Present
Novartis August 2013 - November 2014
Trinity Partners September 2010 - June 2013
L.E.K. Consulting July 2008 - September 2010
McLean Hospital January 2003 - June 2006
Massachusetts General Hospital 2001 - 2006
University of Pennsylvania 1997 - 2000
Califonia Institute of Technology June 1999 - September 1999
Procter & Gamble June 1998 - September 1998
Skills
Portfolio Optimization, Clinical Development, Evidence-based Medicine, Science, Start-ups, Remote Monitoring, Psychiatry, Clinical Trials, Neurology, Cross-functional Team..., Reorganisation, Hepatitis C, Neuroscience, Molecular Biology, Personalized Medicine, Rheumatology, Medical Devices, Product Forecasting, Clinical Research, Restructuring, Due Diligence, Publications, Biotechnology, Biobanking, Statistics, Market Analysis, Deals, Data Analysis, Hardware Diagnostics, Lifesciences, Pharmacogenetics, Reimbursement, Commercialization, P&L Forecasting, Pharmaceutical Industry, Competitive Intelligence, Health Economics, Oncology, Market Research, Research, Outcomes Research, Inflammation, Pricing Research, Management Consulting, eSourcing, Corporate Strategy..., Licensing Strategy, Healthcare